Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
BackgroundCancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378 · cited 1×
“aberrant differentiation of progeny cells [1].”
Self-citationHedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells
Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N.-S., Jackson, K. W., Suri, P., & Wicha, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0054 · Cited by 1,244 · cited 1×
“found to play a role in mammary stem cell self-renewal, including Wnt, Notch, and Hedgehog [2–4].”
BackgroundSelf-citationCharafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173 · cited 1×
“We have previously reported an enrichment of mammary stem/ progenitor cellswithin the cell population expressing ofALDH,which can be detected by the enzymatic Aldefluor assay [19,24].”
BackgroundSelf-citationYost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113 · cited 2×
“This PTEN deficiency also results in the induction of myeloproliferative disorders that progress to leukemia [11,12].”
BackgroundAn integrative genomic and proteomic analysis of pik3ca, pten, and akt mutations in breast cancer.
Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W.-L., Davies, M., Carey, M., Hu, Z., Guan, Y., Sahin, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6854 · Cited by 1,054 · cited 3×
“This was confirmed in a recent report demonstrating that despite harboring a PIK3CA helical mutation, MCF7 cells displayed a low level of AKT phosphorylation [53].”
BackgroundInfluentialRole of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040 · cited 2×
“Activated Akt has been demonstrated to be capable of phosphorylating and inactivating GSK3-b, leading to nuclear translocation and activation of b-catenin [28,29].”
BackgroundMutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946 · cited 1×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
BackgroundPTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S., Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M., et al. (2006) · Nature · doi:10.1038/nature04747 · Cited by 817 · cited 2×
“This PTEN deficiency also results in the induction of myeloproliferative disorders that progress to leukemia [11,12].”
BackgroundSun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 802 · cited 1×
“loop [43–46].”
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774 · cited 1×
“As compared to adherent cultures, normal mammary epithelial cells (NMECs) in mammosphere cultures expressed increased Ser(380) phosphorylation of PTEN (Figure 1A), which results in its conformational changes masking the PDZ binding domain [22].”
BackgroundRole of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
Dontu, G., Jackson, K. W., McNicholas, E., Kawamura, M. J., Abdallah, W. M., & Wicha, M. S. (2004) · Breast Cancer Research · doi:10.1186/bcr920 · Cited by 762 · cited 1×
“found to play a role in mammary stem cell self-renewal, including Wnt, Notch, and Hedgehog [2–4].”
BackgroundSelf-citationRapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755 · cited 1×
“loop [43–46].”
Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, E., & Zhang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702596104 · Cited by 698 · cited 1×
“, recently suggested that the PTEN/mTOR/STAT3 pathway is required for the maintenance of breast cancer stem cells [42].”
BackgroundWNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603 · cited 1×
“Furthermore the Wnt/b-catenin pathway has been shown to play a role in mediating the radiation resistance of mouse mammary progenitor cells [55].”
BackgroundCowden's Disease: A Possible New Symptom Complex with Multiple System Involvement
LLOYD, K. M., & DENNIS, M. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-1-136 · Cited by 580 · cited 1×
“syndrome, which is associated with an increased incidence of breast cancer [35].”
BackgroundStem cells in normal breast development and breast cancer
Dontu, G., Al‐Hajj, M., Abdallah, W. M., Clarke, M. F., & Wicha, M. S. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.36.s.1.6.x · Cited by 578
Self-citationHER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
Korkaya, H., Paulson, A., Iovino, F., & Wicha, M. S. (2008) · Oncogene · doi:10.1038/onc.2008.207 · Cited by 556 · cited 3×
“We previously reported that tumorigenicity in these cell lines is mediated by the Aldefluor-positive population, which is enriched for tumorigenic cancer stem/progenitor cells [31].”
BackgroundInfluentialSelf-citationPTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
Frattini, M., Saletti, P., Romagnani, E., Martin, V, Molinari, F., Ghisletta, M., Camponovo, A., Etienne, L. L., Cavalli, F., & Mazzucchelli, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604009 · Cited by 540 · cited 1×
“The PTEN/ PI3-K/Akt pathway has been described as a major pathway conferring resistance to conventional therapies in multiple tumor types [15–17].”
BackgroundStem cells in normal breast development and breast cancer
Wicha, M., Dontu, G., Al-Hajj, M., & Clarke, M. (2003) · Breast Cancer Research · doi:10.1186/bcr709 · Cited by 537
Self-citationLi, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., Rowlands, T., Egeblad, M., Cowin, P., Werb, Z., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136825100 · Cited by 521 · cited 1×
“, who reported that Wnt-induced mouse mammary tumors show expansion of stem/progenitor population as characterized by increased stem cell markers [54].”
BackgroundHambardzumyan, D., Becher, O. J., Rosenblum, M. K., Pandolfi, P. P., Manova-Todorova, K., & Holland, E. C. (2008) · Genes & Development · doi:10.1101/gad.1627008 · Cited by 468 · cited 1×
“Recent studies suggest that signal transduction pathways including the PTEN/PI3K/Akt play a role in embryonic and tissue-specific stem cell selfrenewal [10,20,21].”
BackgroundHideshima, T., Catley, L., Yasui, H., Ishitsuka, K., Raje, N., Mitsiades, C., Podar, K., Munshi, N. C., Chauhan, D., Richardson, P. G., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3434 · Cited by 422 · cited 2×
“perifosine on PI3-K/Akt signaling has previously been reported [26,27].”
BackgroundPTEN-deficient intestinal stem cells initiate intestinal polyposis
He, X. C., Yin, T., Grindley, J. C., Tian, Q., Sato, T., Tao, W. A., Dirisina, R., Porter-Westpfahl, K. S., Hembree, M., Johnson, T., et al. (2007) · Nature Genetics · doi:10.1038/ng1928 · Cited by 417 · cited 3×
“In addition, Akt can directly phosphorylate b-catenin, an event which further facilitates its nuclear translocation [21].”
BackgroundActivation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
and members of the Southeast Sweden Breast Cancer Group, Pérez-Tenorio, G., & Stål, O. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600126 · Cited by 394 · cited 1×
“with poor prognosis in breast cancer patients [6].”
BackgroundSaal, L. H., Gruvberger-Saal, S. K., Persson, C., Lövgren, K., Jumppanen, M., Staaf, J., Jönsson, G., Pires, M. M., Maurer, M., Holm, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.39 · Cited by 355 · cited 1×
“Humans with germline BRCA1 mutations may also develop microdeletions in the PTEN gene [36].”
BackgroundPhosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
Hollestelle, A., Elstrodt, F., Nagel, J. H. A., Kallemeijn, W. W., & Schutte, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0263 · Cited by 320 · cited 1×
“reported an activating PIK3CAmutation in MCF7 cells, they did not determine whether this mutation resulted in activation of the PI3K/Akt pathway [51].”
BackgroundCancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors
Shafee, N., Smith, C. R., Wei, S., Kim, Y., Mills, G. B., Hortobagyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 308 · cited 2×
“Recent studies have suggested that cancer stem cells, by virtue of their resistance to chemotherapy and radiation therapy, may contribute to tumor resistance and relapse [13,14].”
BackgroundWang, S., Garcia, A. J., Wu, M., Lawson, D. A., Witte, O. N., & Wu, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510652103 · Cited by 308 · cited 2×
“Deletion of PTEN in murine models of prostate cancer results in expansion of the prostate stem/progenitor cell population and initiation of prostate tumors resembling those in humans [10].”
BackgroundWnt Proteins in Mammary Development and Cancer
Brennan, K. R., & Brown, A. M. C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037157.94207.33 · Cited by 248 · cited 1×
“The Wnt/b-catenin pathway has previously been shown to play a role in mammary stem cell function in transgenic mouse models [38].”
BackgroundWnt Signalling in Mammalian Development and Cancer
Smalley, M. J., & Dale, T. C. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006369223282 · Cited by 205 · cited 1×
“found to play a role in mammary stem cell self-renewal, including Wnt, Notch, and Hedgehog [2–4].”
BackgroundMechanisms of Disease: Cancer stem cells--targeting the evil twin
Trumpp, A., & Wiestler, O. D. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1110 · Cited by 199 · cited 1×
“The cancer stem cell hypothesis holds that cancer arises in tissue stem or progenitor cells through dysregulation of the self-renewal process”
BackgroundMunemitsu, S., Albert, I., Rubinfeld, B., & Polakis, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4088 · Cited by 187
Monick, M. M., Carter, A. B., Robeff, P. K., Flaherty, D. M., Peterson, M. W., & Hunninghake, G. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4713 · Cited by 181 · cited 1×
“Thus, by these two mechanisms, Akt activation promotes the activation and accumulation of nuclear b-catenin [49].”
BackgroundPremalignant and In Situ Breast Disease: Biology and Clinical Implications
Arpino, G., Laucirica, R., & Elledge, R. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00009 · Cited by 179 · cited 1×
“All of these histologic characteristics resembled those of atypical ductal hyperplasia, one of the most common premalignant lesions in humans that is believed to be a precursor of DCIS (ductal carcinoma in situ) and invasive ductal carcinoma [40].”
BackgroundWang, X., Yue, P., Chan, C. B., Ye, K., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Fu, H., Khuri, F. R., & Sun, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00760-07 · Cited by 168 · cited 1×
“loop [43–46].”
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
Shoman, N. M., Klassen, S., McFadden, A., Bickis, M., Torlakovic, E., & Chibbar, R. (2004) · Modern Pathology · doi:10.1038/modpathol.3800296 · Cited by 159 · cited 1×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialRadiation resistance and stem-like cells in brain tumors
Hambardzumyan, D., Squartro, M., & Holland, E. C. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.11.008 · Cited by 159 · cited 1×
“Recent studies have suggested that cancer stem cells, by virtue of their resistance to chemotherapy and radiation therapy, may contribute to tumor resistance and relapse [13,14].”
BackgroundReduced expression of PTEN correlates with breast cancer progression
Bose, S., Crane, A., Hibshoosh, H. H., MANSUKHANI, M. M., Sandweiss, L., & Parsons, R. E. (2002) · Human Pathology · doi:10.1053/hupa.2002.124721 · Cited by 153 · cited 1×
“Interestingly, inactivating mutations of PTEN have been reported to be present in these preneoplastic lesions in humans [41].”
BackgroundThe Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia
Leleu, X. P., Jia, X., Runnels, J. M., Ngo, H. T., Moreau, A., Farag, M., Spencer, J. A., Pitsillides, C. M., Hatjiharissi, E., Roccaro, A. M., et al. (2007) · Blood · doi:10.1182/blood-2007-05-092098 · Cited by 144 · cited 2×
“perifosine on PI3-K/Akt signaling has previously been reported [26,27].”
BackgroundReconstruction of human mammary tissues in a mouse model
Proia, D. A., & Kuperwasser, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.31 · Cited by 144 · cited 1×
“Kuperwasser [25] in which NMECs form outgrowths in NOD/ SCID mice whose mammary fat pads have been humanized by”
BackgroundSelective Targeting of Cancer Stem Cells: A New Concept in Cancer Therapeutics
Körkaya, H., & Wicha, M. S. (2007) · BioDrugs · doi:10.2165/00063030-200721050-00002 · Cited by 126
Self-citationSchmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J., Nathan, M., Giacchi, S., Scheiden, R., & Kieffer, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22359 · Cited by 124 · cited 1×
“In prostate tumors, loss of PTEN expression predicts progression to invasive and metastatic disease [9].”
BackgroundHan, Z., Hong, L., Han, Y., Wu, K., Han, S., Shen, H., Li, C., Yao, L., Qiao, T., & Fan, D. (2007) · PubMed · Cited by 95
Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells
Jin, X., Gossett, D. R., Wang, S., Yang, D., Cao, Y., Chen, J. C., Guo, R., Reynolds, R. K., & Lin, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602214 · Cited by 81 · cited 1×
“The effect of perifosine on the PI3-K/Akt pathway has previously been described [26,48].”
BackgroundStem/Progenitor Cells in Mouse Mammary Gland Development and Breast Cancer
Li, Y., & Rosen, J. M. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-2537-2 · Cited by 73 · cited 1×
“b-catenin has been demonstrated to play an important role in the development of mammary stem cells in mouse models [23], suggesting that this pathway may also be active in human mammary stem/progenitor cells in mammospheres.”
BackgroundRegulation of the self-renewal ability of tissue stem cells by tumor-related genes
Naka, K., Ohmura, M., & Hirao, A. (2007) · Cancer Biomarkers · doi:10.3233/cbm-2007-34-504 · Cited by 9 · cited 1×
“renewal [37].”
Cited by
Breast cancer: Biology, biomarkers, and treatments
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S., Safari, E., & Farahmand, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106535 · Cited by 973
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
“…inhibition of GSK3 by Akt may, in certain contexts, lead to stabilization and nuclear translocation of the Wnt target b-catenin (Haq et al. 2003; Korkaya et al. 2009; Ma et al. 2013), a transcriptional regulator whose degradation would otherwise be promoted by GSK3 (Polakis 2001; Korkaya et al.…”
InfluentialSustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Self-citationTsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
“…suspension as tumor spheres and serial passaged to test for self-renewal capacity and stem-like cell activity (Figure 4A) (McDermott andWicha, 2010; Korkaya et al., 2009; Charafe-Jauffret et al., 2009; Dontu et al., 2003; Ginestier et al., 2007; (C) gH2AX foci formation in CD34+ and CD34 Kasumi-1…”
Background
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.